Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy
- PMID: 10950026
- DOI: 10.1111/j.1572-0241.2000.02240.x
Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy
Comment on
-
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.Am J Gastroenterol. 2000 Aug;95(8):2015-22. doi: 10.1111/j.1572-0241.2000.02267.x. Am J Gastroenterol. 2000. PMID: 10950051 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
